2.00
+0.35(+21.21%)
Currency In GBp
Address
Eccleston Yards
London, SW1W 9NF
United Kingdom of Great Britain and Northern Ireland
Phone
44 20 3290 9339
Sector
Healthcare
Industry
Biotechnology
Employees
7
First IPO Date
March 22, 2021
| Name | Title | Pay | Year Born |
| Dr. Darrin Matthew Disley O.B.E., Ph.D. | MD & Director | 24,000 | 1967 |
| Mr. Stephen Paul West B.Com, CA | Executive Chairman | 152,900 | 1972 |
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.